Meeting
2016 ASCO Annual Meeting
Role of inflammation gene polymorphisms on pain and response to radiotherapy in multiple myeloma patients with painful bone destructions.
Authors
Milda Rudzianskiene
Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania
Milda Rudzianskiene , Arturas Inciura , Rolandas Gerbutavicius , Ruta Dambrauskiene , Viktoras Rudzianskas , Elona Juozaityte
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT02024815
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8030)
DOI
10.1200/JCO.2016.34.15_suppl.8030
Abstract #
8030
Poster Bd #
295
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Circulating cytokines and angiogenic factors (CAF) as markers of clinical response in the study of trametinib (T) plus gemcitabine (G) versus placebo (P) plus gemcitabine for patients (pts) with untreated metastatic adenocarcinoma of the pancreas (MEK113487).
First Author: John Heymach
Poster
2020 ASCO Virtual Scientific Program
An in vivo model to evaluate donor-dependent cytokine release in response to single-agent or combination immune-oncology therapies.
First Author: Kyle Draheim
Poster
2019 ASCO Annual Meeting
A donor-dependent in vivo model for single agent and drug combination cytokine release syndrome safety evaluation.
First Author: James G. Keck
Poster
2016 ASCO Annual Meeting
Vitamin D and aromatase inhibitor-induced arthralgia: Analysis of Canadian cancer trial group MA.27 data.
First Author: Polly Ann Niravath